Open Society and Soros Foundation
about usinitiativesgrants and scholarshipsresource centernewsroom
Contact
Search

Stay informed with periodic news about the Public Health Program and related OSI activities. Archive

Soros Foundations

The Public Health Program works closely with individual Soros foundations to implement policies and support local organizations. Find out more about Soros foundations.

Publications

Harm Reduction Developments 2008

Countries with Injection-Driven HIV Epidemics

Date:
March 2008
Source:
OSI

In 2007, injecting drug users (IDUs) comprised the largest share of total HIV cases in at least 20 nations in Asia and the former Soviet Union. The percentage of cases attributed to injecting drug use is over 70 percent in some countries in Eastern Europe and Central Asia, the region where HIV grew fastest in 2006.

In many of these countries, harm reduction has made important inroads—all countries in Eastern Europe and the former Soviet Union except Turkmenistan had needle exchange programs in 2007. In most, they remain too small to contain the HIV epidemic. Reports that new HIV cases among drug users have stabilized often reflect trends in testing rather than the impact of prevention. In Asia, home to more than half the world’s population, even low percentage rates of HIV cases translate into huge numbers of people infected, with profound economic and social implications. China, Indonesia, Malaysia, and Vietnam all have injection-driven HIV epidemics, and have all shown a willingness to adopt some of the measures necessary to halt the spread of HIV among IDUs and their sexual partners. The challenge for many of the hardest-hit countries, however, lies in turning commitments into practice, without sacrificing protection of human rights.

This OSI report provides a snapshot of some key developments in HIV prevention, policy, and treatment for IDUs in developing and transitional countries with injection-driven epidemics, and includes overviews on such issues as community mobilization, methadone and buprenorphine treatment availability, harm reduction in prisons, and HIV treatment for IDUs.

back to the top of the page
share  print  print
FOLLOW OSI
Email Newsletters
News Feeds
Podcasts
Facebook
Twitter

About Us  |  Initiatives  |  Grants, Scholarships & Fellowships  |  Resource Center  |  Newsroom  |  Site Map  |  About this Site  |  Contact


Creative Commons License
Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution-Noncommercial-No Derivative License.
©2009 Open Society Institute. Some rights reserved.

400 West 59th Street  |  New York, NY 10019, U.S.A.  |  Tel 1-212-548-0600

OSI-New York, OSI-Budapest, OSF-London, OSI-Paris and OSI-Brussels are separate organizations that operate independently
yet cooperate informally with each other. This website, a joint presentation, is intended to promote each organization’s interests.